Sep 27, 2019
New Data for BAVENCIO® (avelumab) for Advanced Cancers to Be Presented at ESMO 2019
Sep 20, 2019
CHMP Adopts Positive Opinion for BAVENCIO® (avelumab) Plus Axitinib for First-Line Treatment of Patients with Advanced Renal Cell Carcinoma
Sep 10, 2019
EMD Serono Initiates Pivotal Phase III Program for Investigational Evobrutinib in Relapsing Multiple Sclerosis
Aug 28, 2019
EMD Serono to Showcase Scientific Leadership at ECTRIMS 2019 with New Data Across Multiple Sclerosis Medicines
Jul 16, 2019
EMD Serono's Embracing Carers(TM) Launches 'Time Counts' to Raise 1 Million Minutes of Support for Caregivers
May 28, 2019
EMD Serono to Present Data at CMSC Annual Meeting Showcasing Breadth of MS Portfolio and Commitment to Understanding How MS Impacts Patients
May 14, 2019
FDA Approves BAVENCIO® (avelumab) Plus INLYTA® (axitinib) Combination for Patients with Advanced Renal Cell Carcinoma
May 10, 2019
Positive Phase II Data Further Highlights Clinical Proof of Concept for Evobrutinib, First Oral Bruton's Tyrosine Kinase (BTK) Inhibitor to Report Positive Phase II Clinical Results in MS
May 07, 2019
EMD Serono Launches MS-LINK(TM), a Community to Advance MS Science and Improve Patient Lives
Apr 30, 2019
EMD Serono to Present New Data on Mavenclad®, Rebif® and the Investigational Therapy Evobrutinib at the AAN Annual Meeting 2019
Apr 08, 2019
MAVENCLAD® (Cladribine) Tablets Now Covered by Express Scripts
Mar 29, 2019
FDA Approves MAVENCLAD® (Cladribine) Tablets as First and Only Short-Course Oral Treatment for Relapsing-Remitting and Active Secondary Progressive Multiple Sclerosis
Mar 21, 2019
Agenus Announces Clinical Appointments
Feb 28, 2019
EMD Serono to Present Multiple Sclerosis Data on Cladribine Tablets and Evobrutinib at ACTRIMS 2019
Feb 11, 2019
FDA Accepts sBLA and Grants Priority Review for BAVENCIO® (avelumab) Plus INLYTA® (axitinib) for the Treatment of Advanced Renal Cell Carcinoma
Feb 04, 2019
Elizabeth Varki Jobes, Esq. Joins EMD Serono as Chief Compliance Officer North America
Oct 31, 2018
EMD Serono Launches Community-Based Program to Advance Understanding of the Impact of Multiple Sclerosis on Patients and Caregivers
Oct 25, 2018
EMD Serono and Can Do MS Deliver Educational Programs and Support Groups to Multiple Sclerosis Caregivers
Oct 11, 2018
Global Survey and Documentary Film Expose Emotional Impact of Multiple Sclerosis
Oct 02, 2018
Accelerated Cure Project Announces Collaboration with EMD Serono to Advance Patient-Focused Drug Development in Multiple Sclerosis